Navigation Links
'Beneficial inflammation' may promote healing in pulmonary fibrosis

Inflammation has long been considered an integral part of the biological process that leads to deadly scarring in idiopathic pulmonary fibrosis. New research at National Jewish Health, however, suggests that a little inflammation may also be crucial to the healing and repair processes in the lungs. Elizabeth Redente, PhD, assistant professor of cell biology at National Jewish Health, and her colleagues report in the April 2014 issue of the American Journal of Respiratory Cell and Molecular Biology that the pro-inflammatory cytokine TNF-α can speed recovery of injured lungs and accelerate the resolution of established fibrosis in a mouse model.

"The role of inflammation in the development of scarring has been hotly debated in recent years," said Dr. Redente. "Our findings show for the first time that TNF-α actually promotes inflammation during the resolution of established scarring. A little inflammation may actually be a good thing in the right place and time."

Idiopathic pulmonary fibrosis is a relentless, progressive scarring of the lungs for which there is no approved medical therapy. The disease has no known cause and patients generally die within three years of diagnosis. Approximately 40,000 Americans die of idiopathic pulmonary fibrosis every year.

Inflammation was long believed to be a precursor and cause of scarring in the lungs. However, anti-inflammatory treatments have shown no positive effect on the progress of the disease. In recent years, some researchers have thought that inflammation may be part of the healing process as well as the scarring of the lungs.

Dr. Redente and her colleagues gave mice TNF-α after their lungs had been injured and developed scar tissue. While these mice do normally heal from the lung injury, the researchers found that the TNF-α accelerated the recovery process. It reduced levels of collagen, the main component of scar tissue, and improved the flexibility of lung tissue well before the natural healing process would have begun. The researchers also found that knockout mice lacking the gene for TNF-α failed to heal as wild type mice eventually do.

The researchers believe that TNF-α acts by inducing white blood cells known as macrophages to change from ones that promote fibrosis to ones that promote inflammation instead. TNF-α may also promote the death of some of the pro-fibrotic macrophages.

"Physicians would welcome any therapy that could just slow down or stop the scarring process in the lungs," said David Riches, PhD, professor and head of the program in cell biology at National Jewish Health, and senior author on the study. "Our findings suggest that TNF-α not only slows the fibrotic process, but actually reverses established scarring in the lungs."

The researchers are now investigating the role of TNF-α in various process that actually remove scar tissue including the removal of collagen-producing cells, the degradation and removal of collagen and restoration of healthy lung cells.


Contact: William Allstetter
National Jewish Health

Related medicine news :

1. Is therapeutic hypothermia beneficial in all patients following cardiac arrest?
2. Blood pressure medications given right after stroke not beneficial, study finds
3. Study finds mammography beneficial for younger women
4. Multi-component therapy shown beneficial in treating PTSD in adolescent girls
5. Forbes Living to Broadcast a Beneficial Senior Fitness Segment
6. Weight loss not always beneficial for romantic relationships
7. Milaa Is Set to Introduce an Online Parenting Platform for Today’s Face-Pasted Parents with Activities That Are Beneficial for Their Children’s Development
8. New from Sublime Beauty®: Fresh Citrus Scrub with Beneficial AHAs to Refresh, Invigorate and Gently Exfoliate
9. Researchers Find That Setting Weight Loss Ranges Are More Beneficial than Specifics, Making Weight Loss Via Supplements Like Prescopodene More Likely
10. FDA Review Article Provides New Insights into Cancer Immunotherapy Product Development; Beneficial to all Involved in Cancer Treatment
11. Vitamin C may be beneficial against exercise-induced bronchoconstriction
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... The vast majority of dialysis patients currently ... are usually 3 times a week, with treatment times ... time, equipment preparation and wait time.  This regimen can ... patients who are elderly and frail.  Many elderly dialysis ... centers for some duration of time. Residents ...
(Date:6/23/2016)... YORK , June 23, 2016 ... waters, but it continues to present great opportunities to ... companies for today: Intrexon Corp. (NYSE: XON ... Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), and ... more about these stocks and receive your complimentary trade ...
Breaking Medicine Technology: